A. Sinclair Dunlop
CIK 1721108 · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
46
Lifetime Open-Market Net
-$28.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Director | 0 | $41.03 | $0 | -$28.11M | 46 | 2026-05-14 |
Recent Filings · Page 4 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-24 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −15,000 | -$675.0K | EDGAR |
| 2022-04-25 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +20,000 | $280.0K | EDGAR |
| 2022-01-04 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +4,230 | $0 | EDGAR |
| 2021-09-13 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +6,894 | $96.5K | EDGAR |
| 2021-06-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Other (J) | −16,065 | $0 | EDGAR |
| 2021-05-20 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −162,873 | -$8.56M | EDGAR |
| 2021-04-26 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +10,000 | $140.0K | EDGAR |
| 2021-04-19 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +50,000 | $700.0K | EDGAR |
| 2021-01-04 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −25,000 | -$1.37M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.